Cercar
01/05/2024
Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness
Ruiz-Ramos, J, López-Vinardell, L, Higa-Sansone, L, Torrecilla-Vall-LLossera, B, Puig-Campmany, M, Mangues-Bafalluy, MA, Juanes-Borrego, A. Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness. EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2024; 31(3)DOI:10.1136/ejhpharm-2022-003424. PMID:36100370. IF:1.500(Q4/8D).
19/03/2023
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
Calleja M.A., Albanell J., Aranda E., García-Foncillas J., Feliu A., Rivera F., Oyagüez I., Salinas-Ortega L., Alvarez, JS. Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain. EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; 30(1)DOI:10.1136/ejhpharm-2021-002955. PMID:34810173. IF:1.600(Q3/8D).
01/03/2023
An antidote network in Spain, a tool to improve antidote availability in hospitals
Aguilar-Salmeron, R, Gispert-Ametller, MA, de Gamarra-Martinez, EF, Martinez-Sanchez, L, Garcia-Pelaez, M, Pi-Sala, N, Salgado-Garcia, E, Nogue-Xarau, S. An antidote network in Spain, a tool to improve antidote availability in hospitals. EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; 30(2)DOI:10.1136/ejhpharm-2022-003328. PMID:35501035. IF:1.600(Q3/8D).
01/01/2023
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis
Domingo C., Fernandez M., Garin N., Milara J., Moran I., Muerza I., Pacheco A., Teruel C., Bentley R., Subiran R., Gil A.. Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis. Applied Health Economics and Health Policy. 2023; 21(1)DOI:10.1007/s40258-022-00770-9. PMID:36319945. IF:3.100(Q2/3D).
01/12/2022
Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners
Chazan, G, Jupp, J, Bauters, T, Duncan, N, Weddle, KJ, Nomura, H, O'Connor, S, Chan, A, Alkhudair, N, Alsamrani, M, Buie, LW, Chambers, P, Chieh, TW, DeRemer, DL, Duvivier, F, Katabalo, D, McFarlane, T, Mckavanagh, D, Mensah, K, Martinez, EM, Rowan, G, Sae-teaw, M, Tadesse, TA, Weru, I, Alexander, M. Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2022; 28(8)DOI:10.1177/10781552211048892. PMID:34693814. IF:1.300(Q4/10D).
01/09/2022
Validation protocol of the LESS-CHRON deprescription tool in multimorbidity patients. LESS-CHRON-VALIDATION Project
Rodriguez-de Francisco, L, Rodriguez-Perez, A, Mejias-Trueba, M, Beobide-Telleria, I, Juanes-Borrego, AM, Saavedra-Quiros, V, Carrion-Madronal, IM. Validation protocol of the LESS-CHRON deprescription tool in multimorbidity patients. LESS-CHRON-VALIDATION Project. Farmacia Hospitalaria. 2022; 46(5)DOI:10.7399/fh.13268. PMID:36183233. IF:(Q/D).
01/09/2022
PAUSATE Study: Prevalence and appropriateness of the use of antimicrobials in Spanish hospitals
Gutierrez-Urbon, JM, Arenere-Mendoza, M, Fernandez-de-Gamarra-Martinez, E, Fernandez-Polo, A, Gonzalez-Suarez, S, Nicolas-Pico, J, Rodriguez-Mateos, ME, Sanchez-Yanez, E. PAUSATE Study: Prevalence and appropriateness of the use of antimicrobials in Spanish hospitals. Farmacia Hospitalaria. 2022; 46(5)DOI:10.7399/fh.13152. PMID:36183227. IF:(Q/D).
01/09/2022
Drug-drug interactions in an intensive care unit and comparison of updates in two databases
Riera, P, Sole, N, Suarez, JC, Lopez, PA, Fonts, N, Rodriguez-Farre, N, de Gamarra-Martinez, EF, Moran, I. Drug-drug interactions in an intensive care unit and comparison of updates in two databases. Farmacia Hospitalaria. 2022; 46(5)DOI:10.7399/fh.13180. PMID:36183229. IF:(Q/D).